These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 33217066)

  • 41. High-risk oral leukoplakia is associated with aberrant promoter methylation of multiple genes.
    Abe M; Yamashita S; Mori Y; Abe T; Saijo H; Hoshi K; Ushijima T; Takato T
    BMC Cancer; 2016 Jun; 16():350. PubMed ID: 27255271
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Clinicopathological characteristics of malignant transformation in 85 cases of oral leukoplakia].
    Gao Y; Guo ZL; Luo HY; Wang J
    Zhonghua Kou Qiang Yi Xue Za Zhi; 2012 Jul; 47(7):410-3. PubMed ID: 22931571
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Increased genetic damage in oral leukoplakia from high risk sites: potential impact on staging and clinical management.
    Zhang L; Cheung KJ; Lam WL; Cheng X; Poh C; Priddy R; Epstein J; Le ND; Rosin MP
    Cancer; 2001 Jun; 91(11):2148-55. PubMed ID: 11391596
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Malignant transformation of oral leukoplakia: a follow-up study.
    Jayasooriya PR; Dayaratne K; Dissanayake UB; Warnakulasuriya S
    Clin Oral Investig; 2020 Dec; 24(12):4563-4569. PubMed ID: 32436158
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Diagnosis and treatment of oral precancerous lesions].
    Sudbø J; Warloe T; Aamdal S; Reith A; Bryne M
    Tidsskr Nor Laegeforen; 2001 Oct; 121(26):3066-71. PubMed ID: 11757442
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The treatment of oral leukoplakia with the CO2 laser: A retrospective study of 65 patients.
    Mogedas-Vegara A; Hueto-Madrid JA; Chimenos-Küstner E; Bescós-Atín C
    J Craniomaxillofac Surg; 2015 Jun; 43(5):677-81. PubMed ID: 25913630
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Malignant transformation of Taiwanese patients with oral leukoplakia: A nationwide population-based retrospective cohort study.
    Wang TY; Chiu YW; Chen YT; Wang YH; Yu HC; Yu CH; Chang YC
    J Formos Med Assoc; 2018 May; 117(5):374-380. PubMed ID: 29428194
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Evaluation of MAGE-A expression and grade of dysplasia for predicting malignant progression of oral leukoplakia.
    Ries J; Agaimy A; Vairaktaris E; Kwon Y; Neukam FW; Strassburg LH; Nkenke E
    Int J Oncol; 2012 Sep; 41(3):1085-93. PubMed ID: 22751922
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Molecular alterations of mitochondrial D-loop in oral leukoplakia.
    Elamir A; ElRefai SM; Ghazy SE
    J Cell Biochem; 2019 Aug; 120(8):13944-13951. PubMed ID: 30945332
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Nomogram for risk prediction of malignant transformation in oral leukoplakia patients using combined biomarkers.
    Zhang X; Kim KY; Zheng Z; Bazarsad S; Kim J
    Oral Oncol; 2017 Sep; 72():132-139. PubMed ID: 28797449
    [TBL] [Abstract][Full Text] [Related]  

  • 51. DNA content status using brush biopsy with image cytometry correlated with staging of oral leukoplakia: a preliminary study.
    Xiao X; Shi L; Li H; Song Y; Liu W; Zhou Z
    Oral Oncol; 2015 Jan; 51(1):59-63. PubMed ID: 25459158
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Potentially malignant disorders of the oral cavity: current practice and future directions in the clinic and laboratory.
    Dionne KR; Warnakulasuriya S; Zain RB; Cheong SC
    Int J Cancer; 2015 Feb; 136(3):503-15. PubMed ID: 24482244
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Ultrastructural variations and assessment of malignant transformation risk in oral leukoplakia.
    Kannan S; Balaram P; Pillai MR; Chandran GJ; Nair MK; Kartha CC; Augustine J; Sudha L; Mangalam MK
    Pathol Res Pract; 1993 Dec; 189(10):1169-80. PubMed ID: 8183737
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Histopathological and immunohistochemical study of malignant transformation of oral leukoplakia, with special reference to apoptosis-related gene products and proliferative activity.
    Nogami T; Kuyama K; Yamamoto H
    Acta Otolaryngol; 2003 Aug; 123(6):767-75. PubMed ID: 12953781
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Loss of heterozygosity and immunoexpression of PTEN in oral epithelial dysplasia and squamous cell carcinoma.
    Chaves FN; Bezerra TMM; Moraes DC; Costa SFDS; Silva PGB; Alves APNN; Costa FWG; Bernardes VF; Pereira KMA
    Exp Mol Pathol; 2020 Feb; 112():104341. PubMed ID: 31730755
    [TBL] [Abstract][Full Text] [Related]  

  • 56. p53 expression in oral precancer and cancer.
    Rich AM; Kerdpon D; Reade PC
    Aust Dent J; 1999 Jun; 44(2):103-5. PubMed ID: 10452165
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Molecular genetics of premalignant oral lesions.
    Mithani SK; Mydlarz WK; Grumbine FL; Smith IM; Califano JA
    Oral Dis; 2007 Mar; 13(2):126-33. PubMed ID: 17305612
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Prevalence of Carcinomatous Foci in Oral Leukoplakia: A Clinicopathologic Study of 546 Indian Samples.
    Gopinath D; Thannikunnath BV; Neermunda SF
    J Clin Diagn Res; 2016 Aug; 10(8):ZC78-83. PubMed ID: 27656569
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Aberrations of erbB-1 and erbB-2 oncogenes in non-dysplastic leukoplakias of the oral cavity.
    Werkmeister R; Brandt B; Joos U
    Br J Oral Maxillofac Surg; 1999 Dec; 37(6):477-80. PubMed ID: 10687911
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Integrative analysis of genomic and transcriptomic data of normal, tumour, and co-occurring leukoplakia tissue triads drawn from patients with gingivobuccal oral cancer identifies signatures of tumour initiation and progression.
    Ghosh A; Das C; Ghose S; Maitra A; Roy B; Majumder PP; Biswas NK
    J Pathol; 2022 Aug; 257(5):593-606. PubMed ID: 35358331
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.